Wize Pharma, Inc. Human Resources Contracts & Agreements
25 Contracts & Agreements
- Bonus & Incentive Agreements (11 contracts)
- Consulting Agreements (3)
- Employment Agreements (11)
- Companys 2024 Omnibus Equity Incentive Plan (Filed With SEC on August 19, 2024)
- Form Of Stock Option Grant Notice And Option Agreement Under Companys 2024 Omnibus Equity Incentive Plan (Filed With SEC on August 19, 2024)
- Addendum to Employment Agreement by and between Mawson Infrastructure Group, Inc. and Rahul Mewawalla, dated December 26, 2023 (Filed With SEC on April 1, 2024)
- Addendum to Employment Agreement by and between Mawson Infrastructure Group, Inc. and Rahul Mewawalla, dated July 19, 2023 (Filed With SEC on April 1, 2024)
- Employment Agreement by and between Mawson Infrastructure Group Inc. and Rahul Mewawalla, dated May 22, 2023 (Filed With SEC on April 1, 2024)
- Addendum to Employment Agreement by and between Mawson Infrastructure Group Inc. and Rahul Mewawalla, dated December 26, 2023 (Filed With SEC on December 29, 2023)
- Addendum dated July 19, 2023 to Employment Agreement between Mawson Infrastructure Group, Inc. and Rahul Mewawalla (Filed With SEC on July 21, 2023)
- Employment Agreement by and between Mawson Infrastructure Group Inc. and Rahul Mewawalla, dated May 22, 2023 (Filed With SEC on May 25, 2023)
- 2021 Equity Incentive Plan (Filed With SEC on March 23, 2023)
- Employment Agreement between Mawson Infrastructure Group Pty Ltd and Nicholas Hughes-Jones dated October 8, 2021 (Filed With SEC on October 8, 2021)
- Employment Agreement of Hetal Majithia dated August 19, 2021 (Filed With SEC on August 20, 2021)
- Employment Agreement between Mawson Infrastructure Group Inc. and Liam Daniel Wilson (Filed With SEC on August 12, 2021)
- Addendum Agreement, between Wize Pharma, Inc. and Bonus BioGroup Ltd., dated November 29, 2020 (Filed With SEC on November 30, 2020)
- Amendment to Letter Agreement (SPA), dated July 1, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)
- Letter Agreement (SPA), dated June 24, 2020, by and between the Company and Bonus BioGroup Ltd (Filed With SEC on August 14, 2020)
- Share Purchase Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)
- Exchange Agreement by and between Bonus BioGroup Ltd. and Wize Pharma Inc., dated January 9, 2020 (Filed With SEC on January 15, 2020)
- Consulting Agreement (Filed With SEC on November 14, 2018)
- Amendment No. 1 to Consulting Services Agreement (Filed With SEC on November 14, 2018)
- Consulting Services Agreement, dated August 20, 2018, between Wize Pharma Ltd., N. Danenberg Holdings (2000) Ltd. and Noam Danenberg (Filed With SEC on August 22, 2018)
- Employment Agreement, dated August 21, 2018, between Wize Pharma Ltd. And Or Eisenberg (Filed With SEC on August 22, 2018)
- Amendment to 2018 Equity Incentive Plan (Filed With SEC on August 21, 2018)
- 2018 Stock Incentive Plan (Filed With SEC on February 28, 2018)
- Employment Agreement dated September 30, 2015 between Wize Pharma Ltd. and Or Eisenberg (unofficial English translation from Hebrew) (Filed With SEC on July 27, 2017)
- Exhibit 4.1 OPHTHALIX INC. 2012 STOCK INCENTIVE PLAN (Filed With SEC on February 9, 2012)
